Oh! Here, I’ll be unboxing the latest and classic booster packs, so you always know what to expect. Stay informed about the newest card releases and get in-depth reviews on all the exciting cards as ...

Oh! with this loaded Rarity Collection box – insane pulls and nostalgia! #RarityCollection #YuGiOh25th #AnniversarySet ...

We’re on Day 2 of the draft, and Day 1 saw the Jaguars trade up with the Cleveland Browns to draft two-way Heisman winner, Travis Hunter, out of Colorado. But perhaps the biggest story is who didn’t ...

Konami Digital Entertainment Inc. rolled out the inaugural episode of its new promotional short-animation series for the Yu-Gi-Oh! Trading Card Game today on the ...

Venture through the Labyrinth Of The Demon King, solving puzzles and fighting fearsome monsters in an epic quest to track down the demon who betrayed your lord and end its life. It was meant to ...

The first episode of Yu-Gi-Oh Card Game The Chronicles, starring Sky Striker Ace – Raye, is now available worldwide. The next episode will appear in May 2025.

Forbes contributors publish independent expert analyses and insights. I write about entrepreneurship, AI, and the future of work.

[SINGAPORE] Alleged nickel fraudster Ng Yu Zhi had “five families” – his wife, ex-wife and three girlfriends – one of his former employees told the High Court on Wednesday (Apr 16). This prosecution ...

The Christchurch man behind a major black market tobacco operation has been jailed for more than three years. Zijing Yu, 42, was arrested in June last year after an illicit cigarette factory was ...

SINGAPORE – Less than a year after he paid $490,000 for a Bentley Mulsanne, alleged fraudster Ng Yu Zhi traded in the luxury car for an Aston Martin Rapide he bought for a man who is believed to ...

San Diego Padres right-handed pitcher Yu Darvish began throwing off a mound for the first time since mid-March. Even though the Padres have had a hot start, the team is still missing one of their ...

Ironwood Pharmaceuticals is mulling its options after the FDA demanded another phase 3 trial before it will make an approval decision on the biopharma’s long-acting GLP-2 analog. The drug ...